首页 >
法规速递
-
国家药监局关于调整《医疗器械分类目录》部分内容的公告（2025年第132号）-2026/1/4
2026-01-05查看详情 > -
国家药监局关于参倍固肠胶囊和儿童清咽解热口服液转换为非处方药的公告（2026年第19号）-2026/2/10
2026-02-10查看详情 > -
Document: Questions and answers on the refusal of a change to the marketing authorisation for Hetlioz (tasimelteon) (X-39)-2026/3/17
2026-03-18查看详情 > -
Document: Annex to agenda of the CHMP meeting 20-23 April 2026-2026/4/20
2026-04-21查看详情 > -
Document: Concept paper on the development of a reflection paper on the use of External controls for evidence generation in regulatory decision-making-2026/6/3
2026-06-04查看详情 > -
国家药监局药审中心关于发布《放射性体内治疗药物临床评价技术指导原则》的通告（2023年第9号）-2023/02/15
2023-02-15查看详情 > -
Final Guidance: Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex: Developing Drugs for Treatment-2023/9/1
2023-09-04查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第八十八批）的通告（2025年第1号）-2025/1/6
2025-01-06查看详情 > -
Page: Submission deadlines for orphan designations-2025/2/6
2025-02-10查看详情 > -
Document: User guide for micro, small and medium-sized enterprises-2025/3/14
2025-03-17查看详情 >
